I 
116TH CONGRESS 
2D SESSION 
H. R. 8059 
To direct the Secretary of Homeland Security to submit to Congress a 
report on the security and resilience of the United States medical supply 
chains, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
AUGUST 14, 2020 
Mr. TRONE (for himself and Mr. JOYCE of Pennsylvania) introduced the fol-
lowing bill; which was referred to the Committee on Energy and Com-
merce, and in addition to the Committees on Homeland Security, and 
Transportation and Infrastructure, for a period to be subsequently deter-
mined by the Speaker, in each case for consideration of such provisions 
as fall within the jurisdiction of the committee concerned 
A BILL 
To direct the Secretary of Homeland Security to submit 
to Congress a report on the security and resilience of 
the United States medical supply chains, and for other 
purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Strengthening our 
Health Security Through Resilient Medical Supply Chains 
Annual Review Act of 2020’’. 
VerDate Sep 11 2014 
01:35 Sep 03, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H8059.IH
H8059
pbinns on DSKJLVW7X2PROD with BILLS
SEC. 2. REPORT ON SECURITY AND RESILIENCE OF THE 
UNITED STATES MEDICAL SUPPLY CHAINS. 
(a) IN GENERAL.—Not later than one year after the 
date of the enactment of this Act, and annually thereafter, 
the Secretary of Homeland Security shall submit to the 
Committee on Homeland Security of the House of Rep-
resentatives, and the Committee on Homeland Security 
and Government Affairs of the Senate a report on the se-
curity and resilience of the United States medical supply 
chains. Such a report shall contain a classified annex. The 
Secretary shall make publicly available (including by publi-
cation on the website of the Department of Homeland Se-
curity) the unclassified portion of the report. 
(b) CONTENTS.—The report submitted under sub-
section (a) shall— 
(1) review the United States supply chains for 
medical devices, supplies, and drugs and the vulner-
ability of such supply chains to a global disruption, 
such as an instance of bioterrorism, a natural dis-
aster, or a public health emergency; 
(2) assess the dependence of the United States 
on any medical devices, equipment, supplies, coun-
termeasures, vaccines, and drugs produced or 
sourced outside the United States; and 
(3) identify the actions the Federal government 
has taken during the year covered by the report— 
VerDate Sep 11 2014 
01:35 Sep 03, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H8059.IH
H8059
pbinns on DSKJLVW7X2PROD with BILLS
(A) to promote the security and resilience 
of the United States medical supply chain; 
(B) to improve medical supply chain re-
dundancy; 
(C) to encourage the domestic production 
of medical devices, equipment, supplies, coun-
termeasures, vaccines, and drugs; and 
(D) to develop contingency plans for poten-
tial global disruptions; and 
(4) provide recommendations to agencies of the 
Federal Government, States, local, tribal, and terri-
torial governments, and the private sector on ways 
to strengthen the security and resilience of the 
United States medical supply chain. 
(c) CONSULTATION.—In preparing the report under 
subsection (a), the Secretary of Homeland Security— 
(1) shall consult with the heads of other rel-
evant Federal agencies; and 
(2) may consult with public health experts, 
health security experts, supply chain experts, and 
other individuals with relevant experience. 
Æ 
VerDate Sep 11 2014 
01:35 Sep 03, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H8059.IH
H8059
pbinns on DSKJLVW7X2PROD with BILLS